Publication:
CONCOMITANT USE OF CORTICOSTEROIDS AT THE BASELINE DOES NOT AFFECT THE DRUG SURVIVAL OF ABATACEPT IN RHEUMATOID ARTHRITIS

dc.contributor.authorİNANÇ, GÜZİDE NEVSUN
dc.contributor.authorsKoca, S. S.; Oz, B.; Karatas, A.; Dalkilic, H. E.; Can, G.; Pehlivan, Y.; Senel, S.; Yazici, A.; Inanc, N.; Cefle, A.; Erturk, Z.; Akar, S.; Yagiz, B.; Goker, B.; Birlik, A. M.; Onen, F.
dc.date.accessioned2022-03-12T04:21:53Z
dc.date.accessioned2026-01-11T19:01:23Z
dc.date.available2022-03-12T04:21:53Z
dc.date.issued2018-06
dc.identifier.doi10.1136/annrheumdis-2018-eular.5819
dc.identifier.eissn1468-2060
dc.identifier.issn0003-4967
dc.identifier.urihttps://hdl.handle.net/11424/223802
dc.identifier.wosWOS:000444351001568
dc.language.isoeng
dc.publisherBMJ PUBLISHING GROUP
dc.relation.ispartofANNALS OF THE RHEUMATIC DISEASES
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleCONCOMITANT USE OF CORTICOSTEROIDS AT THE BASELINE DOES NOT AFFECT THE DRUG SURVIVAL OF ABATACEPT IN RHEUMATOID ARTHRITIS
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage597
oaire.citation.startPage597
oaire.citation.titleANNALS OF THE RHEUMATIC DISEASES
oaire.citation.volume77

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
743.44 KB
Format:
Adobe Portable Document Format